Amphastar Pharmaceuticals Ownership | Who Owns Amphastar Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Amphastar Pharmaceuticals Ownership Summary


Amphastar Pharmaceuticals is owned by 69.47% institutional investors, 24.02% insiders, and 6.52% retail investors. Blackrock is the largest institutional shareholder, holding 12.33% of AMPH shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 4.74% of its assets in Amphastar Pharmaceuticals shares.

AMPH Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAmphastar Pharmaceuticals69.47%24.02%6.52%
SectorHealthcare Stocks 486.50%11.08%-397.59%
IndustrySpecialty & Generic Drug Manufacturers Stocks43.67%11.42%44.91%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock5.94M12.33%$237.70M
Blackrock funding, inc. /de5.67M12.07%$130.16M
Vanguard group2.71M5.58%$100.79M
Td asset management1.84M3.79%$68.33M
State street1.60M3.28%$59.26M
Pacer advisors1.35M2.78%$50.14M
Fuller & thaler asset management1.26M2.69%$29.02M
Epoch investment partners1.24M2.64%$28.50M
Dimensional fund advisors lp1.20M2.47%$44.50M
Boston trust walden978.92K2.01%$36.35M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Lam group130.80K3.46%$4.86M
Mesirow institutional investment management380.39K1.09%$14.12M
Bridge city capital138.64K0.89%$3.18M
Aurora investment counsel53.25K0.64%$1.22M
Boston trust walden978.92K0.26%$36.35M
Systematic financial management lp359.31K0.22%$8.25M
Significant wealth partners16.18K0.18%$371.45K
Epoch investment partners1.24M0.15%$28.50M
Virtus fund advisers1.22K0.14%$45.30K
Pacer advisors1.35M0.11%$50.14M

Top Buyers

HolderShares% AssetsChange
Pacer advisors1.35M0.11%1.35M
Millennium management868.55K0.01%612.00K
Boston trust walden978.92K0.26%439.28K
Qube research469.49K0.01%210.51K
Voloridge investment management325.51K0.03%109.51K

Top Sellers

HolderShares% AssetsChange
Neuberger berman group---1.37M
Federated hermes823.49K0.07%-1.12M
Blackrock funding, inc. /de5.67M0.00%-478.87K
Boston partners---423.07K
Granite investment partners---375.78K

New Positions

HolderShares% AssetsChangeValue
Empowered funds85.11K0.02%85.11K$1.95M
Arrowstreet capital, limited partnership81.24K0.00%81.24K$1.87M
Jump financial63.33K0.02%63.33K$1.45M
Susquehanna portfolio strategies39.56K0.02%39.56K$908.39K
Edgestream partners37.11K0.02%37.11K$852.09K

Sold Out

HolderChange
Financial gravity asset management-1.00
Sjs investment consulting-1.00
Jfs wealth advisors-3.00
Nelson, van denburg & campbell wealth management group-7.00
Bruce g. allen investments-9.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2025237-2.47%32,613,359-1.94%691.43%13214.78%70-25.53%
Mar 31, 20255-98.12%1,063,934-97.00%20.04%3-97.50%2-98.02%
Dec 31, 2024261-7.45%35,408,7620.08%721.38%116-18.31%1007.53%
Sep 30, 20242802.94%35,359,6972.73%721.47%140-93-4.12%
Jun 30, 2024268-1.83%34,405,3022.58%711.47%1382.99%96-1.03%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
iShares Core S&P Small-Cap ETF2.20M4.74%386.00
FullerThaler Behavioral Sm-Cp Eq R61.21M2.56%126.06K
FullerThaler Behavioral Small-Cap Equity1.21M2.56%126.06K
Vanguard Total Stock Mkt Idx Inv1.14M2.46%-25.35K
Vanguard US Total Market Shares ETF1.14M2.40%1.24K
TD U.S. Capital Reinvestment I920.14K1.93%-27.55K
iShares Russell 2000 ETF877.56K1.89%-16.70K
Neuberger Berman Genesis Inv794.66K1.65%-271.05K
Federated Hermes Kaufmann R615.00K1.26%-
Federated Hermes Kaufmann Small Cap A522.39K1.10%-31.39K

Recent Insider Transactions


DateNameRoleActivityValue
Aug 01, 2025Petersen Floyd F.-Sell$10.42K
Jul 02, 2025Petersen Floyd F.-Sell$11.73K
Jun 02, 2025Petersen Floyd F.-Sell$12.84K
May 01, 2025Petersen Floyd F.-Sell$12.04K
Apr 01, 2025Petersen Floyd F.-Sell$14.19K

Insider Transactions Trends


DateBuySell
2025 Q3-1
2025 Q2-3
2025 Q1-2
2024 Q4-7
2024 Q3-5

AMPH Ownership FAQ


Who Owns Amphastar Pharmaceuticals?

Amphastar Pharmaceuticals shareholders are primarily institutional investors at 69.47%, followed by 24.02% insiders and 6.51% retail investors. The average institutional ownership in Amphastar Pharmaceuticals's industry, Specialty & Generic Drug Manufacturers Stocks, is 43.67%, which Amphastar Pharmaceuticals exceeds.

Who owns the most shares of Amphastar Pharmaceuticals?

Amphastar Pharmaceuticals’s largest shareholders are Blackrock (5.94M shares, 12.33%), Blackrock funding, inc. /de (5.67M shares, 12.07%), and Vanguard group (2.71M shares, 5.58%). Together, they hold 29.98% of Amphastar Pharmaceuticals’s total shares outstanding.

Does Blackrock own Amphastar Pharmaceuticals?

Yes, BlackRock owns 12.33% of Amphastar Pharmaceuticals, totaling 5.94M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 237.7M$. In the last quarter, BlackRock decreased its holdings by -137K shares, a -2.25% change.

Who is Amphastar Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Lam group is Amphastar Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 3.46% of its assets in 130.8K Amphastar Pharmaceuticals shares, valued at 4.86M$.

Who is the top mutual fund holder of Amphastar Pharmaceuticals shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of Amphastar Pharmaceuticals shares, with 4.74% of its total shares outstanding invested in 2.2M Amphastar Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools